| Literature DB >> 28324644 |
Johanna Huchting1, Matthias Winkler1, Hiba Nasser1, Chris Meier1.
Abstract
T-705 (favipiravir) is a fluorinated hydroxypyrazine carboxamide that exhibits antiviral activities against a variety of RNA viruses. Given the lack of potent agents to combat these infections caused by a large number of high-impact pathogens, significant emphasis has been put on studies of the antiviral properties of T-705 and its mechanism of action. T-705 acts as a nucleobase analogue; it is therefore metabolized to the corresponding ribonucleoside triphosphate intracellularly. Herein we report a reliable synthesis of T-705-ribonucleoside as well as its 5'-monophosphate. Moreover, we disclose detailed studies on the remarkable lability of the heterocycle when attached to ribose under very mild conditions, as typically applied in biochemical studies.Entities:
Keywords: T-705; antiviral agents; favipiravir; nucleosides; pyrazine ribonucleosides
Mesh:
Substances:
Year: 2017 PMID: 28324644 DOI: 10.1002/cmdc.201700116
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466